In muscle tear models, the combination addresses both the inflammatory response and the structural repair phase simultaneously with BPC-157 modulating pro-inflammatory cytokines (TNF-, IL-6) and oxidative stress markers, and TB-500 recruiting progenitor cells and mesenchymal cells to the post-injury site while BPC-157 drives their subsequent differentiation and organisation
Individuals who have undergone gastrointestinal surgery, particularly gastric bypass or removal of parts of the stomach or small intestine (especially the terminal ileum), are at significantly increased risk due to reduced intrinsic factor production or loss of absorption sites
Begin with 250mcg daily for the first week to assess tolerance
In rodent models, BPC-157 accelerates tendon healing, gastric ulcer closure, skin and muscle wound repair, and recovery from several forms of induced injury [2]
A mild, short reaction is common and recognised